Drug Shortage Report for ACT-HIB
Report ID | 4464 |
Drug Identification Number | 01959034 |
Brand name | ACT-HIB |
Common or Proper name | Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate) |
Company Name | SANOFI PASTEUR LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN |
Strength(s) | 10 μG 30 μG |
Dosage form(s) | Powder For Solution |
Route of administration | INTRAMUSCULAR |
Packaging size | 5 x 0.5 mL vials / 5 fioles de 0,5 mL |
ATC code | J07AG |
ATC description | BACTERIAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-03-28 |
Actual start date | 2017-03-28 |
Estimated end date | 2017-11-15 |
Actual end date | 2018-01-18 |
Shortage status | Resolved |
Updated date | 2018-01-22 |
Company comments | Act-Hib lot# UI880AA was released to the market on January 18, 2018. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-01-22 | French | Compare |
v9 | 2018-01-22 | English | Compare |
v8 | 2018-01-22 | French | Compare |
v7 | 2018-01-22 | English | Compare |
v6 | 2017-03-29 | French | Compare |
v5 | 2017-03-29 | English | Compare |
v4 | 2017-03-28 | French | Compare |
v3 | 2017-03-28 | English | Compare |
v2 | 2017-03-28 | French | Compare |
v1 | 2017-03-28 | English | Compare |
Showing 1 to 10 of 10